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We studied the relationship between cAMP and
house dust mite-induced cytokine production in T
cells from mite-sensitive patients with atopic derma-
titis. T cells from atopic dermatitis patients secreted
high level of interleukin-13 (mean 851.1 pg perml)
when cultured with autologous monocytes pulsed
with Dermatophagoides pteronyssinus extract. Dermato-
phagoides pteronyssinus-induced interleukin-13 secre-
tion was not detected in normal subjects. Adenylate
cyclase inhibitor MDL 12,330A and cyclic nucleotide
phosphodiesterase type 4 inhibitor rolipram blocked
Dermatophagoides pteronyssinus-induced interleu-
kin-13 secretion in atopic dermatitis T cells. In ato-
pic dermatitis T cells, cAMP level rose at 5 min after
Dermatophagoides pteronyssinus stimulus then decreased
to the basal level at 1 h. MDL 12,330A blocked the
Dermatophagoides pteronyssinus-induced cAMP eleva-
tion while rolipram blocked its reversal. In atopic
dermatitis T cells, adenylate cyclase activity
increased at 5 min after Dermatophagoides pteronyssinus
stimulus, followed by the increase of cyclic nucleo-
tide phosphodiesterase acvity at 15 min. In atopic
dermatitis T cells, phospholipase C inhibitor ET-18-
OCH3 blocked Dermatophagoides pteronyssinus-induced
activation of adenylate cyclase, while rolipram, pro-
tein kinase A inhibitor H-89, and MDL 12,330A
blocked the activation of cyclic nucleotide phospho-
diesterase. These results suggest that Dermatophagoides
pteronyssinus may ®rst increase cAMP in atopic der-
matitis T cells by activating adenylate cyclase via
phospholipase C, and next decrease cAMP by acti-
vating cyclic nucleotide phosphodiesterase 4 via pro-
tein kinase A, which may be activated by adenylate
cyclase-generated cAMP signal. These events are
required for interleukin-13 response Dermatophagoides
pteronyssinus. Key words: adenylate cyclase/cyclic nucleotide
phosphodiesterase/Dermatophagoides pteronyssinus. J
Invest Dermatol 116:3±11, 2001
H
ouse dust mite allergen plays an important part in
the development of allergic diseases such as atopic
dermatitis (AD) (Nakagawa et al, 1987; Wedder-
burn et al, 1993; Lu et al, 1998). The production of
house dust mite-speci®c IgE antibodies is highly
enhanced in atopic patients compared with nonatopic subjects, and
this triggers allergic responses (Lu et al, 1998). It is reported that T
cells from atopic patients respond to mite allergen and predomi-
nantly produce T helper-2 (Th2) cytokines such as interleukin (IL)
±4, IL-5, or IL-6, which stimulate humoral immunity. In contrast,
the mite-induced production of Th1 cytokines such as interferon
(IFN) -g, IL-2, or lymphotoxin, which stimulate cellular immune
responses, is impaired in atopic T cells (Wierenga et al, 1991). It is
also reported that Dermatophagoides pteronyssinus (Dp) -induced IL-
13 production is enhanced in atopic donors (Lu et al, 1998; Kimura
et al, 2000). IL-13 is a more recently de®ned cytokine and shares
many functional properties with IL-4 (Minty et al, 1993). In
particular, IL-13 induces B cell IgE production by isotype
switching (Wedderburn et al, 1993; Lu et al, 1998). The precise
mechanism for the allergen-induced IL-13 production, however,
has not been de®ned. It is recently reported that 3¢,5¢-adenosine
cyclic monophosphate (cAMP)-elevating agents inhibit ragweed
allergen-induced IL-13 production in the allergen-speci®c T cell
clones from atopic donors (Essayan et al, 1997). Cellular cAMP
levels are controlled by the balance of adenylate cyclase (AC),
which synthesizes cAMP, and cyclic nucleotide phosphodiesterase
(PDE) which hydrolyzes cAMP (Robicsek et al, 1991; Iyengar,
1993). Thus cAMP elevation is induced by AC stimulators, such as
prostaglandin E2, forskolin, or cholera toxin, and by PDE
inhibitors, such as theophylline or 3-isobutyl-1-methylxanthine
(Anastassiou et al, 1992; Essayan et al, 1997). PDE is an isozymic
Manuscript received January 14, 2000; revised June 26, 2000; accepted
for publication September 26, 2000.
Reprint requests to: Dr. Naoko Kanda, Department of Dermatology,
Teikyo University, School of Medicine, 11±1, Kaga-2, Itabashi-Ku, Tokyo
173-8605, Japan. Email: nmk@med.teikyo-u.ac.jp
Abbreviations: AC, adenylate cyclase; AD, atopic dermatitis; AP-1,
activating protein-1; ATF-1, activation transcriptional factor-1; BAPTA/
AM, 1,2-bis(o-aminophenoxy)ethane-N,N,N¢,N¢-tetraacetic acid tetra(a-
cetoxymethyl)ester; cAMP, 3¢,5¢-adenosine cyclic monophosphate;
CREB, 3¢,5¢-adenosine cyclic monophosphate-responsive element-bind-
ing protein; Dp, Dermatophagoides pteronyssinus; ET-18-OCH3, 1-O-
octadecyl-2-O-methyl-rac-glycero-3-phosphorylcholine; H-89, N-[2-((p-
bromocinnamyl)amino)ethyl]-5-isoquinolinesulfonamide; IP3, inositol
1,4,5-triphosphate; MDL 12,330A, cis-N-(2-phenylcyclopentyl)azacyclo-
tridec-1-en-2-amine hydrochloride; 8mmIBMX, 8-methoxymethyl-3-
isobutyl-1-methylxanthine; PDE, cyclic nucleotide phosphodiesterase;
PPD, puri®ed protein derivative; Rp-8-Br-cGMPS, guanosine 3¢,5¢-cyclic
monophosphorothioate, 8-bromo-, rp-isomer; W-7, N-(6-aminohexyl)-5-
chloro-1-naphthalenesulfonamide.
0022-202X/01/$15.00 ´ Copyright # 2001 by The Society for Investigative Dermatology, Inc.
3
family composed of various subtypes (Robicsek et al, 1991), and a
previous study reported that a cAMP-speci®c PDE (PDE)4
inhibitor suppressed allergen-induced IL-13 production (Essayan
et al, 1997).
It is known that the cAMP-elevating agents suppress phytohe-
magglutinin-induced or calcium ionophore/phorbol 12-myristate
13-acetate-induced production of Th1 cytokines such as IFN-g or
IL-2 (Anastassiou et al, 1992; Yoshimura et al, 1998). It is suggested
that protein kinase A, activated by the binding of cAMP, may
downregulate the transcriptional, or pretranscriptional or post-
transcriptional site of Th1 gene expression (Anastassiou et al, 1992;
Penix et al, 1996). In contrast, regarding the regulation of Th2
production by cAMP, con¯icting results are reported. Lacour et al
(1994) reported that cAMP-elevating agents upregulated IL-4 and
IL-5 production of ionophore/phorbol 12-myristate 13-acetate-
activated murine CD4+ T cells, and suggested that cAMP may
switch the T cell cytokine pro®le towards Th2. On the other hand,
Borger et al (1996) reported that cAMP-elevating agents suppressed
IL-4 production of concanavalin A-activated human T cells or anti-
CD3/anti-CD28-activated human T cells. Essayan et al (1995)
reported that cAMP-elevating agents did not alter ragweed
antigen-induced IL-4 production by human peripheral blood
mononuclear cells. Possibly the modulatory effects of cAMP on
Th2 production may vary depending on the T cell sources used and
the stimulation conditions applied. IL-13 is preferentially expressed
in Th2-type cells; however, it is also expressed in some Th1 clones
or Th0 clones that produce IL-2 or IFN-g together with IL-4 or
IL-5 (De Waal Malefyt et al, 1995). It is thus possible that cAMP
may regulate IL-13 production differently from other prototypic
Th2 cytokines, such as IL-4 or IL-5.
In this study, we ®rst examined mite allergen-induced cytokine
production in T cells from mite-sensitive AD patients and normal
subjects. The allergen potently and speci®cally induced IL-13
production in the patients' T cells. We then analyzed the regulatory
effect of cAMP on the mite-induced IL-13 production with regard
to the activities of AC and PDE.
MATERIALS AND METHODS
Patients and controls We studied 20 patients with mild to severe AD
[10 men and 10 women, age 25.2 6 1.4 y (mean 6 SEM)], diagnosed
according to the criteria by Hani®n and Rajka (1980). Their disease
severity was scored according to the grading by Rajka and Langeland
(1989), and the score was 5.0 6 0.4 (mean 6 SEM). Serum total IgE and
IgE antibody speci®c for Dp were determined by chemiluminescence
enzyme immunoassay using the LUMIWARD automated allergy system
(Shionogi, Osaka, Japan). All patients showed elevated serum Dp-speci®c
IgE (> 0.7 IU per ml; chemiluminescence enzyme immunoassay class > 2).
The Dp-speci®c IgE value of the patients was 31.1 6 7.1 IU per ml and
total IgE value was 4708 6 1607 U per ml (mean 6 SEM). The patients'
peripheral blood eosinophil count was 939 6 153 per ml, and serum lactic
dehydrogenase value was 341 6 26 U per l (mean 6 SEM). At the time of
the study, 16 of 20 patients were treated with topical corticosteroids that
were ranked mild to very strong. No patients were taking systemic
corticosteroids, anti-allergic or anti-histaminic drugs, or receiving
desensitization immunotherapy. Nonatopic healthy volunteers [seven
men and eight women, age 26.4 6 2.1 y (mean 6 SEM)] were studied as
controls. None of the controls had symptoms indicative of allergic diseases,
or receiving medication, and their serum Dp-speci®c IgE value was
< 0.35 IU per ml; chemiluminescence enzyme immunoassay class 0. At the
time of the investigation, all the patients and controls did not have active
infection by fungi, viruses, or bacteria, and consumed no beverage
containing caffeine or methylxanthine for at least 8 h before drawing blood.
All the patients and controls were informed of the objectives and methods
of this study, and consented to participate.
Reagents The crude extract from Dp was purchased from Cosmo Bio
(Tokyo, Japan). Mycobacterium tuberculosis puri®ed protein derivative (PPD)
was from Evans Medical Ltd (Horsham, Sussex, U.K.). Rolipram, 8-
methoxymethyl-3-isobutyl-1-methylxanthine (8mmIBMX), milrinone,
cis-N-(2-phenylcyclopentyl)azacyclotridec-1-en-2-amine hydrochloride
(MDL 12,330A) were obtained from Calbiochem (La Jolla, CA), and
were dissolved in dimethylsulfoxide as 10 mM stock solutions. 1-O-
octadecyl-2-O-methyl-rac-glycero-3-phosphorylcholine (ET-18-OCH3)
was from Calbiochem and was dissolved in ethanol as 10 mM stock
solution. Calphostin C, N-[2-((p-bromocinnamyl)amino)ethyl]-5-iso-
quinolinesulfonamide (H-89), N-(6-aminohexyl)-5-chloro-1-naphtha-
lenesulfonamide (W-7), and 1,2-bis(o-aminophenoxy)ethane-N,N,N¢,N¢-
tetraacetic acid tetra(acetoxymethyl)ester (BAPTA/AM) were obtained
from Calbiochem, and were dissolved in dimethylsulfoxide as 10 mM stock
solutions. Guanosine 3¢,5¢-cyclic monophosphorothioate, 8-bromo-, rp-
isomer (Rp-8-Br-cGMPS) from Calbiochem was dissolved in distilled
water as 10 mM stock solution. All the stock solutions above were kept in
the dark until used.
Preparation of monocytes and T cells Peripheral blood mononuclear
cells were isolated by centrifugation over Ficoll-Paque (Pharmacia,
Uppsala, Sweden) as described (Boyum, 1968), and were allowed to
adhere to plastic dishes for 2 h at 37°C. From the adherent cells, CD3±,
CD19±, and CD56± cells were isolated by negative selection using
immunomagnetic beads (Dynal, Great Neck, NY) as described (Gee et al,
1987), and used as monocytes. This monocyte population was > 97%
CD14+, and the contamination of CD3+, CD19+, or CD56+ cells was
< 1% by ¯ow cytometry. From the nonadherent cells, CD56± cells were
isolated by negative selection using immunomagnetic beads (Dynal), and
were incubated with neuraminidase-treated sheep erythrocytes as described
(Farrant et al, 1985). From the rosette-forming cells, CD14± and CD19±
cells were isolated by immunomagnetic negative selection, and were used
as T cells. This T cell population was > 98% CD3+, and the contamination
of CD14+, CD19+, or CD56+ cells was < 2%.
Measurement of cytokines We used endotoxin-, hormone-, and
serum-free medium, 1:1 mixture of Dulbecco's modi®ed Eagle's medium
and Ham's Nutrient Mixture F-12 (Sigma, St. Louis, MO), supplemented
with 365.1 mg per l L-glutamine (Gibco/BRL, Grand Island, NY).
Monocytes were irradiated (25 Gy) and used as antigen-presenting cells.
Monocytes (5 3 104) were seeded in triplicate on to 96-well plates and
cultured with or without Dp extract or prototypic Th1-antigen PPD (each
10 mg per ml) in total 200 ml medium for 3 h at 37°C (antigen pulse). The
plates were centrifuged, and washed three times with medium. Autologous
T cells (2 3 105) were then added and cultured with Dp- or PPD-pulsed or
nonpulsed monocytes in total 200 ml medium at 37°C in an atmosphere of
5% CO2 in air for 48 h. The culture supernatants were harvested and stored
at ±70°C until used. The activity of IFN-g, IL-4, or IL-13 in the culture
supernatants was measured by an enzyme-linked immunosorbent assay kit
(Biosource, Tokyo, Japan) according to the manufacturer's instruction. The
sensitivity of the assay for IFN-g, IL-4, or IL-13 was 4, 3, or 12 pg per ml,
respectively. The antigen-induced cytokine secretion of T cells was
calculated as cytokine concentration of the culture with antigen-pulsed
monocytes minus that of the culture with nonpulsed monocytes
(background secretion). We considered positive response to antigen if
the antigen-induced cytokine secretion was > 10 pg per ml and more than
background.
For the analysis of cytokine mRNA expression, reverse transcription±
polymerase chain reaction (reverse transcription±PCR) was performed.
Nonadherent cells (> 95% CD3+, < 2% CD14+) were harvested from the
combined culture of T cells and monocytes after 12 h, and were used as T
cells. Total RNA was extracted from the harvested T cells, and was reverse
transcribed as described (Kanda, 1999). Primer sequences for cytokines and
for the internal control b-actin as well as PCR conditions are described
elsewhere (Jung et al, 1996; Jaffar et al, 1999; Kanda, 1999). The PCR
products were analyzed by electrophoresis on 2.5% agarose gels and stained
with ethidium bromide. The intensity of the band for each cytokine PCR
product was determined by densitometry (Hoefer Scienti®c Instruments,
San Francisco, CA) and the ratio relative to b-actin product was calculated.
Measurement of cAMP To measure cAMP level of T cells at various
time points, T cells harvested as described above were lyzed with ethanol,
and the lysates were centrifuged and the supernatants were dried under
vacuum. The dried samples were dissolved in acetate buffer (pH 5.8), and
cellular cAMP contents were measured by enzyme-linked immunosorbent
assay (Amersham, Arlington Heights, IL) according to the manufacturer's
instructions. The sensitivity of the assay was 12 fmol per assay well. At each
time point, the number of the harvested cells was recounted in parallel and
cAMP level was presented as pmol per 106 cells.
Proliferation assays T cells were cultured in triplicate with autologous
irradiated antigen-pulsed or nonpulsed monocytes as described above for
40 h, and 0.5 mCi per well of [3H]thymidine (Amersham) was added and
the cells were incubated for an additional 8 h prior to harvest. The
incorporation of [3H]thymidine was assayed by liquid scintillation.
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Generation of short-term Dp-speci®c Th1 cell line Dp-speci®c Th1
cell lines were generated from peripheral blood mononuclear cells as
described (Del Preto et al, 1991). Brie¯y, peripheral blood mononuclear
cells from AD or normal subjects were cultured with Dp (10 mg per ml) in
24-well-bottomed plates for 12 d, the last 7 d in the presence of 20 U per ml
human recombinant IL-2 (Cetus, Emeryville, CA). Viable T blasts were
harvested and tested for the Dp-speci®c proliferation and cytokine
secretion using irradiated autologous monocytes as antigen-presenting
cells. Dp-speci®c Th1 cell lines were de®ned as the T blasts showing Dp-
speci®c proliferation (Dp-induced increase of [3H]thymidine uptake
> 10,000 cpm) and high IFN-g response to Dp (> 500 pg per ml)
without IL-4 or IL-13 response to Dp (< 10 pg per ml). Dp-speci®c Th1
cell lines could be generated from three of 10 normal donors, whereas they
could not be generated from the 10 AD patients.
Measurement of PDE activity At various time points of the culture, T
cells harvested as described above were sonicated at 2 3 107 per ml, and the
cell lysate was assayed for PDE activity as described (Robicsek et al, 1991)
using 1 mM of [2,8±3H]cAMP (30 Ci per mmol) (Amersham) as a substrate.
Each assay was performed in triplicate, and results were presented as pmol
cAMP hydrolyzed per min per mg protein.
Measurement of membrane AC activity The T cell lysate obtained as
described above was centrifuged at 23,600 3 g, and the pellet was used as
the membrane fraction as described (Choi et al, 1992). The AC activity of
the membrane fraction was assayed as described (Salomon et al, 1974) using
1 mM [a-32P]adenosine triphosphate (30 Ci per mmol) (Amersham) as a
substrate. Each assay was performed in triplicate, and results were presented
as pmol cAMP formed per min per mg protein.
Measurement of inositol 1,4,5-triphosphate (IP3) T cells were
incubated in a medium containing 10 mM LiCl with autologous antigen-
pulsed or nonpulsed monocytes for 3 min. Nonadherent T cells were
harvested as described above, and after washing, soluble phosphates were
extracted with 0.2 vol. of ice-cold 20% HClO4 for 20 min. After
centrifugation at 2000 3 g at 4°C for 15 min the supernatants were
neutralized with Tris±KOH. IP3 was quanti®ed with a radioreceptor assay
system from Amersham, and was presented as pmol per 106 cells.
Statistical analyses Mann±Whitney U test was used for the comparison
of mean amounts in AD and normal groups in Fig 1. Fisher's exact test was
used for the difference in the incidence of positive cytokine response
between the two groups in Fig 1. For the data in Fig 3, one-way analysis of
variance with Dunnet's multiple comparison test was used. For the data in
Figs 2 and 8 and Table I, one-way analysis of variance with Scheffe's
multiple comparison test was used. Spearman's correlation coef®cient was
determined in the data for Table II and Fig 6. A value of p < 0.05 was
considered signi®cant.
RESULTS
Cytokine production in response to Dp T cells from Dp-
sensitive AD patients and normal donors were cultured with
autologous Dp-pulsed or nonpulsed monocytes, and IL-13, IL-4,
and IFN-g secretion were measured. The Dp-induced IL-13
secretion was markedly higher in AD patients (mean 6 SEM,
851.1 6 249.3 pg per ml) than that in controls (±0.1 6 1.3 pg
per ml, p < 0.0001) (Fig 1a). None of the normal subjects showed
a positive IL-13 response to Dp, and the incidence of the positive
response was higher in AD patients than that in controls
(p < 0.0001). We analyzed the correlation of Dp-induced IL-13
secretion in the AD patients with their clinical parameters
(Table II). Dp-induced IL-13 secretion strongly correlated with
Dp-speci®c IgE values and did not correlate with other parameters,
disease severity score, total IgE, eosinophil count, or lactic
dehydrogenase value. This indicates that Dp-induced IL-13
secretion may contribute to the synthesis of Dp-speci®c IgE
antibody in vivo. In contrast, Dp-induced IL-4 and IFN-g secretion
were very low both in AD and normal groups (maximally < 20 pg
per ml). There were no signi®cant differences in the incidence or
the mean amount of IL-4 (Fig 1b) and IFN-g (Fig 1c) secretion
between the two groups. The further enhanced IL-4 or IFN-g
secretion induced by Dp was not detected either in AD or normal
T cells at the culture period of 6, 12, 24, or 72 h (data not shown).
In contrast to Dp, PPD induced high IFN-g secretion both in
AD (mean 6 SEM, 233.1 6 38.2 pg per ml) and normal
(225.0 6 40.1 pg per ml) groups, and there was no difference in
the incidence or mean amount (Fig 1f). PPD-induced IL-13
(Fig 1d) and IL-4 (Fig 1e) secretion was very low (maximally
< 30 pg per ml) in both AD and normal groups, and there were no
differences in the incidence or mean amount.
We also examined the antigen-induced cytokine mRNA
expression. When nonadherent cells were harvested from the
combined culture of T cells and monocytes, this population was
> 95% CD3+ and < 2% CD14+. The cytokine mRNA expression
in this nonadherent population was analyzed by reverse transcrip-
tion±PCR (Fig 2). The results in mRNA expression were parallel
to those in protein secretion; Dp induced IL-13 mRNA expression
only in AD T cells, whereas PPD induced IFN-g mRNA
expression equivalently in AD and normal T cells. Both Dp and
PPD only slightly increased IL-4 mRNA levels in AD and normal
T cells and the difference from controls without antigens was not
signi®cant (Fig 2b), indicating that the low levels of IL-4 secretion
(Fig 1b, e) may not be due to consumption by T cells.
Thus Dp speci®cally and greatly induced IL-13 production in
AD T cells, whereas it induced very low levels of IFN-g and IL-4
production. The subsequent experiments will be thus focused on
Dp-induced IL-13 production in AD T cells. We aimed to clarify
the mechanism for the Dp-induced IL-13 production regarding the
cAMP-related signaling pathways.
The modulation of Dp-induced IL-13 secretion by the
enzymes related to cAMP metabolism We ®rst examined the
involvement of cAMP-synthesizing AC and cAMP-hydrolyzing
PDE in Dp-induced IL-13 secretion of AD T cells. T cells were
preincubated with PDE or AC inhibitors before the culture with
Dp-pulsed monocytes, and their inhibitory effects on IL-13
secretion were compared. As shown in Fig 3(a) AC inhibitor
MDL 12,330A concentration dependently inhibited Dp-induced
IL-13 secretion (IC50 = 0.2 mM), and complete inhibition was
detected at 5 mM. Rolipram, an inhibitor of cAMP-speci®c PDE
Table I. The IP3 increase and proliferation in response to Dp
or PPDa
Antigen IP3 (pmol per 106 cells) Proliferation (cpm)
AD Nonatopic AD Nonatopic
(n = 5) (n = 3) (n = 5) (n = 3)
None 0.223 6 0.071 0.297 6 0.093 1003 6 210 2505 6 526
Dp 0.631 6 0.143b 1.095 6 0.283b 5975 6 1,023b 22 523 6 3,432b
PPD 0.682 6 0.165b 0.325 6 0.111 6585 6 1,503b 2925 6 663
aT cells from AD patients and Dp-speci®c Th1 cell lines from nonatopic donors
were cultured with autologous Dp-pulsed or PPD-pulsed or nonpulsed
monocytes, and IP3 level was measured at 3 min, whereas proliferation was assayed
at 48 h as described in Materials and Methods. The data are mean 6 SEM.
bp < 0.01 versus control cultures with antigen-nonpulsed monocytes.
Table II. The correlation of Dp-induced IL-13 secretion
with clinical parameters in AD patients (n = 20)
Parameters rs
a p
Dp-speci®c IgE 0.923 <0.0001
Total IgE ±0.120 0.6019
Eosinophil count 0.284 0.2153
Lactic dehydrogenase value ±0.201 0.3812
Disease severity score ±0.087 0.7037
aSpearman's correlation coef®cient.
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(PDE4) also completely inhibited Dp-induced IL-13 secretion
(IC50 = 0.1 mM). In contrast, neither cGMP-inhibited PDE (PDE3)
inhibitor milrinone, nor Ca2+/calmodulin-dependent PDE (PDE1)
inhibitor 8mmIBMX suppressed the Dp-induced IL-13 secretion.
These results suggest that both AC and PDE4 may be required,
whereas PDE1 and PDE3 may not be required for the Dp-induced
IL-13 secretion in AD T cells.
In comparison, the effects of AC or PDE inhibitors were assessed
on antigen-induced IFN-g secretion. As shown in Fig 3(b), PPD-
induced IFN-g secretion in AD T cells identical to those in Fig 3(a)
was inhibited by rolipram but not by MDL 12,330A, and the
similar results were obtained in normal donors' T cells (data not
shown). To know the AC or PDE inhibitors' effects on Dp-
induced IFN-g secretion, we tried to generate short-term Dp-
speci®c Th1 cell lines as described in Materials and Methods, and the
cell lines were obtained from normal donors. The attempt to
generate Dp-speci®c Th1 cell lines from AD patients was
unsuccessful (data not shown). As shown in Fig 3(c), Dp-induced
IFN-g secretion in Dp-speci®c Th1 cell lines from normal donors
was completely blocked by rolipram, but not by MDL 12,330A.
These results suggest that both Dp-induced IFN-g secretion and
PPD-induced IFN-g secretion may involve PDE4 but not AC.
Kinetics of intracellular cAMP level in AD T cells cultured
with Dp-pulsed monocytes We next tried to examine the
kinetics of cAMP level of T cells after incubation with antigen-
pulsed monocytes. As shown in Fig 4, cAMP level of AD T cells
increased 4-fold above the basal level at 5 min of the culture with
Dp-pulsed monocytes, then decreased, and returned to the basal
level at 1 h. The early rise of cAMP was blocked by AC inhibitor
MDL 12,330A, suggesting that AC activity may be enhanced in the
Figure 1. Dp- or PPD-induced IL-13, IL-4, and IFN-g secretion of
T cells from AD patients and normal subjects. (a, d) IL-13, (b, e) IL-4,
(c, f) IFN-g Each point represents the mean of triplicate cultures from
individual donors. Bars show the group means. Values in parentheses are
the number of donors with positive cytokine response/total donor number.
The following are background cytokine secretion without antigens in AD
patients versus normal subjects and p-value in the comparison by Mann±
Whitney U test: IL-13 52.9 6 8.9 (mean 6 SEM) versus 22.1 6 3.6 pg
per ml, p = 0.0037; IL-4 4.2 6 0.6 versus 4.1 6 0.7 pg per ml, p = 0.8752;
IFN-g 8.1 6 1.0 versus 7.1 6 1.4 pg per ml, p = 0.6935.
Figure 2. Dp- or PPD-induced cytokine mRNA expression. mRNA
expression for IL-13, IL-4, and IFN-g was analyzed by reverse
transcription±PCR in T cells after 12 h culture with autologous antigen-
pulsed or nonpulsed monocytes. (a) Representative results are shown from
a single culture event of an AD patient's and normal donor's T cells. (b)
Densitometry data are depicted for all AD patients (n = 20) and normal
donors (n = 15) for each cytokine. The intensity ratio relative to b-actin
PCR band was calculated for each cytokine band, and was normalized for
control value without antigens, which is de®ned as 1.0. *p < 0.05 versus
control without antigens.
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early phase (< 5 min). In contrast, PDE4 inhibitor rolipram
retained the elevated cAMP level, suggesting that PDE4 may
reverse the early rise of cAMP. As opposed to Dp, Th1 antigen
PPD did not alter cAMP level in the identical AD T cells. Besides
Dp did not alter cAMP level in a short-term Dp-speci®c Th1 cell
line from a normal donor. These results suggest that the alteration
of cAMP level after antigen stimulus may be speci®c to Dp-
stimulated AD T cells and may not occur in PPD-stimulated AD T
cells or Dp-stimulated Dp-speci®c Th1 cell line from a normal
donor. We then studied the kinetics of AC and PDE activities in
the AD T cells after culture with Dp-pulsed monocytes.
Kinetics of AC and PDE activities in AD T cells cultured
with Dp-pulsed monocytes The AC activity in AD T cells was
increased and peaked at 5 min of the culture with Dp-pulsed
monocytes, then decreased, and returned to the basal level at
30 min (Fig 5a). The transient AC activation was speci®cally
blocked by AC inhibitor MDL 12,330A, and not by PDE4
inhibitor rolipram. Th1 antigen PPD did not induce the activation
of AC in the identical AD T cells. Dp did not induce the activation
of AC in the Dp-speci®c Th1 cell line from a normal donor. Thus
the antigen-induced activation of AC may be speci®c to Dp-
stimulated AD T cells.
On the other hand, PDE activity of AD T cells was also
enhanced by the Dp stimulus (Fig 5b), although the enhancement
occurred later than that of AC (Fig 5a). The PDE activity increased
and was peaked at 15 min, then gradually decreased, and returned
to the basal level at 1 h. Rolipram blocked the Dp-induced
activation of PDE, suggesting that PDE4 may be activated among
PDE subtypes. Preincubation with MDL 12,330A suppressed the
Dp-induced activation of PDE. The suppression by MDL 12,330A
may not be due to the direct inhibition of PDE enzyme as the
direct addition of MDL 12,330A to the PDE assay did not reduce
the PDE activity as compared with controls (data not shown). As
MDL 12,330A blocked the activation of AC prior to that of PDE
(Fig 5a), it is indicated that the initial activation of AC may be
required for the following activation of PDE. Th1 antigen PPD did
not induce the activation of PDE in AD T cells. Dp did not induce
the activation of PDE in the Dp-speci®c Th1 cell line from a
normal donor. We then analyzed the correlation of the Dp-induced
AC or PDE activation with Dp-induced IL-13 secretion. Dp-
induced IL-13 secretion strongly correlated both with the Dp-
induced increase in AC activity (Fig 6a) and with that of PDE
(Fig 6b). These indicate that both the activation of AC and PDE by
Dp may contribute to IL-13 induction by Dp.
The relationship of Dp-induced T cell receptor (TCR)
stimulation with AC and PDE activation The antigenic
Figure 3. The inhibitory effects of AC and PDE inhibitors on
antigen-induced cytokine secretion. (a) T cells from ®ve AD patients
(two men and three women) were preincubated for 30 min with medium
alone or with medium containing AC or PDE inhibitors at indicated doses,
washed and then added to the autologous Dp-pulsed or nonpulsed
monocytes pre-adhered to 96-well plates. IL-13 secretion was examined
after 48 h. Background IL-13 secretion was 51.3 6 7.8 pg per ml (mean 6 -
SEM, n = 5). (b) T cells identical to those in (a) were similarly treated
except that PPD was used as an antigen and IFN-g secretion was tested.
Background IFN-g secretion was 9.0 6 1.3 pg per ml (mean 6 SEM, n = 5).
(c) Dp-speci®c Th1 cell lines from normal donors (n = 3, one man and two
women) were similarly treated using Dp as an antigen, and IFN-g secretion
was tested. Background IFN-g secretion was 30.0 6 6.3 pg per ml
(mean 6 SEM, n = 3). Values are the mean 6 SEM. * p < 0.05 versus
control cultures without inhibitors.
Figure 4. Kinetics of intracellular cAMP level of T cells after Dp or
PPD stimulus. T cells from an AD patient were preincubated for 30 min
with medium alone or with medium containing MDL 12,330A or rolipram
(each 5 mM). The cells were washed and then added to the autologous Dp-
or PPD-pulsed or nonpulsed monocytes. Dp-speci®c Th1 cell line from a
normal donor was similarly treated in parallel. Intracellular cAMP level of T
cells was analyzed at the indicated time points of the culture. The
mean 6 SD of triplicate cultures is shown. The data are representative of
three separate experiments using three different AD patients' T cells and
three different Th1 cell lines from normal donors.
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epitope(s) derived from Dp may be presented on a monocyte
surface in the context of MHC molecules (Fig 7). When the
antigen/MHC complex interacts with the TCR/CD3 complex on
the T cell surface, the interaction may trigger the activation of
phospholipase C (PLC), which is closely linked to the TCR/CD3
complex. Though TCR/CD3 complex does not directly couple to
AC, it is reported that PLC-mediated signals may indirectly activate
AC (Kvanta et al, 1990; Bihoreau et al, 1991). The activated PLC
hydrolyzes phosphatidyl inositol and generates IP3 and
diacylglycerol; the former mobilizes Ca2+ from the intracellular
store, whereas the latter activates protein kinase C and induces its
translocation to the membrane (Fig 7) (Patel et al, 1987; Park et al,
1992). It is reported that intracellular Ca2+ forms complex with
cytosolic calmodulin and the Ca2+/calmodulin complex binds to
AC and activates this enzyme, whereas protein kinase C directly
activates AC by phosphorylation (Iyengar, 1993). We thus tested if
the Dp-induced activation of AC in AD T cells may also involve
PLC-mediated signals. We preincubated AD T cells with various
signal transducing enzyme inhibitors, such as PLC or protein kinase
C inhibitor, and examined their inhibitory effects on Dp-induced
activation of AC. When AD T cells were preincubated with the
PLC inhibitor ET-18-OCH3, the Dp-induced activation of AC
was completely blocked (Fig 8a), suggesting the involvement of
PLC in Dp-induced activation of AC. Dp-induced activation of
AC was also blocked by chelating intracellular Ca2+ with BAPTA/
AM, indicating the involvement of Ca2+ signal in AC activation.
The Dp-induced activation of AC was also partially blocked by
calmodulin antagonist W-7 or protein kinase C inhibitor calphostin
C, respectively, and the usage of both agents gave additive
inhibitory effects and resulted in complete inhibition. This indicates
that protein kinase C and Ca2+/calmodulin may independently
stimulate AC. These totally suggest that Dp-induced activation of
AC may be mediated by PLC-induced two second messengers,
intracellular Ca2+ signal and activated protein kinase C. As Ca2+
functions as a cofactor for protein kinase C, Ca2+ may be required
for both protein kinase C-mediated stimulation of AC and Ca2+/
calmodulin-mediated stimulation of AC. This possibility is
supported by the results that BAPTA/AM completely, not
partially, inhibited the Dp-induced activation of AC.
We then analyzed if Dp may activate PLC in AD T cells, by
measuring the level of IP3, which is the product of PLC-mediated
hydrolysis of phosphatidyl inositol. Dp increased the IP3 level in
AD T cells, indicating the activation of PLC by the Dp stimulus
(Table I); however, Dp also increased the IP3 level in Dp-speci®c
Th1 cell lines from normal donors, and PPD increased the IP3 level
in AD T cells, although in these systems the antigens did not
activate AC (Fig 5a). PPD did not increase IP3 level in Dp-speci®c
Th1 cell lines from normal donors. As PLC-mediated signals are
known to induce proliferation (Nishizuka, 1984), we examined the
proliferative response to Dp or PPD in AD or normal T cells. The
results on proliferation mostly paralleled those of IP3; Dp enhanced
Figure 5. Kinetics of AC and PDE activity of T cells after Dp or
PPD stimulus. (a) AC activity; (b) PDE activity. T cells from an AD
patient and Dp-speci®c Th1 cell line from a normal donor, which are
identical to those in Fig 4, were treated as described in Fig 4 legend. The
AC and PDE activities of the T cells were analyzed at the indicated time
points of the culture. Data are the mean 6 SD of triplicate assays. The data
are representative of three separate experiments using three different AD
patients' T cells and three different Th1 cell lines from normal donors.
Figure 6. Relationship between Dp-induced IL-13 secretion and
Dp-induced increase of AC activity or that of PDE activity in T
cells from AD patients. (a) AC activity; (b) PDE activity. T cells were
isolated from 20 AD patients identical to those in Fig 1. AC activity of the
T cells was analyzed at 5 min, that of PDE was analyzed at 15 min, and IL-
13 secretion was analyzed at 48 h of the culture with autologous Dp-pulsed
or nonpulsed monocytes, respectively. The Dp-induced increase of AC or
PDE activity was calculated as AC or PDE activity of T cells cultured with
Dp-pulsed monocytes minus that of T cells with nonpulsed monocytes
(background activity), respectively. Background IL-13 secretion was
52.9 6 8.9 pg per ml (mean 6 SEM, n = 20), and background AC and
PDE activities were 23.5 6 4.5 pmol per min per mg protein, and
26.3 6 5.6 pmol per min per mg protein, respectively.
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[3H]thymidine uptake both in AD T cells and in Dp-speci®c Th1
cell lines from normal donors. PPD enhanced [3H]thymidine
uptake only in AD T cells, and did not in Dp-speci®c Th1 cell lines
from normal donors. Thus the antigen-induced activation of PLC
may commonly occur in Dp-stimulated AD T cells, Dp-stimulated
Dp-speci®c Th1 cell lines from normal donors, and PPD-
stimulated AD T cells; however, the antigen-induced activation
of AC may only occur in Dp-stimulated AD T cells. This is
possibly because the sensitivity of AC to the activation by PLC-
mediated signals may be highly enhanced in the Dp-responsive T
cell population from AD patients and/or another different signal
which potentiates the PLC-mediated AC activation may act in such
T cell population.
The Dp-induced activation of PDE was speci®cally blocked by
rolipram, and not by 8mmIBMX or milrinone (Fig 8b), suggesting
that PDE4 may be speci®cally activated by Dp among PDE
subtypes. The Dp-induced activation of PDE was completely
blocked by AC inhibitor MDL 12,330A, and by protein kinase A
inhibitor H-89, and was not affected by protein kinase G inhibitor
Rp-8-Br-cGMPS. These totally suggest that AC and protein kinase
A may be involved in the activation of PDE4 by Dp. As AC
generates the cAMP signal and cAMP activates protein kinase A
(Fig 7), it is indicated that an early cAMP signal via the Dp-induced
activation of AC (Figs 4 and 5a) may activate protein kinase A, and
the activated protein kinase A may contribute to the activation of
PDE4. This possibility is also supported by the strong correlation
between the Dp-induced increase of AC activity and that of PDE
in AD patients (rs = 0.931, n = 20, p < 0.0001).
DISCUSSION
This study demonstrated that T cells from Dp-sensitive AD patients
speci®cally produced IL-13 in response to Dp. The Dp stimulus (i)
increased cAMP level of AD T cells by activating AC, and (ii)
reduced its level by activating PDE. Both events were speci®c to
Dp-sensitive AD patients, and were required for IL-13 induction
by Dp. Dp-induced IL-13 secretion strongly correlated with the
Dp-speci®c IgE value, suggesting that Dp-induced IL-13 produc-
tion may contribute to the synthesis of Dp-speci®c IgE antibody.
Though it is known that IL-4 enhances whereas IFN-g suppresses
IgE synthesis of B cells (Punnonen and de Vries, 1994), IL-4 and
IFN-g responses to Dp in AD patients were very low and were not
different from those in normal donors at protein and mRNA levels.
This indicates that neither IL-4 nor IFN-g may be involved in the
production of Dp-speci®c IgE. The IFN-g response to Dp,
however, may be latently reduced in AD T cells relative to normal
T cells; the short-term culture generated Th1 cell lines showing an
IFN-g response to Dp in normal donors whereas it could not in AD
patients. Thus the impairment of an IFN-g response to Dp may also
be related to the increased production of Dp-speci®c IgE antibody
in AD patients. We are now trying to establish Dp-speci®c T cell
clones from AD patients, and to examine their cytokine pro®le and
ability to enhance Dp-speci®c IgE synthesis of autologous B cells in
vitro.
The early rise of cAMP (< 5 min) after the Dp stimulus was
required for IL-13 production and thus seems to be at least one of
the triggering signals for IL-13 induction. As cAMP activates
protein kinase A, this kinase may upregulate the early step of IL-13
production. One possible mechanism for the upregulation is that
protein kinase A may phosphorylate certain transcription factors
involved in IL-13 gene expression and thus promote their activity.
It is reported that protein kinase A enhances the transcriptional
stimulatory activity of activator protein-2 (AP-2) on several genes
containing the AP-2 element (Gao et al, 1997; Garcia et al, 1999);
the AP-2 element is also present in the 5¢-¯anking region of IL-13
genes (Smirnov et al, 1995). Other cAMP-related transcription
factors, such as cAMP-responsive element-binding protein
(CREB) or activation transcriptional factor-1 (ATF-1), may also
be involved in IL-13 gene expression, although their roles in IL-13
transcription have not been identi®ed.
The previous studies suggest the cross-talk interaction between
TCR/CD3-mediated signals and cAMP (Bihoreau et al, 1991). It is
reported that stimulation of TCR/CD3 by anti-CD3 increased
cAMP levels in human Jurkat T cells (Kvanta et al, 1990; Bihoreau
et al, 1991). In this system, the stimulation of TCR/CD3 activated
PLC, and the PLC-induced second messengers, protein kinase C
activation and/or intracellular Ca2+ signal appeared to activate AC
(Fig 7) (Bihoreau et al, 1991; Iyengar, 1993). To date, eight
different isotypes of AC have been isolated, and these different
types are localized in a tissue-type-speci®c manner and a cell-type-
speci®c manner (Iyengar, 1993). Protein kinase C stimulates AC
types 2 and 7, and Ca2+/calmodulin stimulates AC types 1 and 3,
Figure 7. The schematic diagram for antigen-induced signaling cascade related to cAMP and the effects of agonists and antagonists. A solid
arrow with (+) means stimulation whereas a dotted arrow with (±) means suppression, respectively. Abbreviations used: AC, adenylate cyclase; Ag, antigen;
CalC, calphostin C; DAG, diacylglycerol; IP3, inositol 1,4,5-triphosphate; MHC, major histocompatibility complex; PDE, cyclic nucleotide
phosphodiesterase; PIP2, phosphatidylinositol 4,5-bisphosphate; PKA, protein kinase A; PKC, protein kinase C; PLC, phospholipase C; TCR, T cell
receptor.
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although Ca2+ directly inhibits AC types 5 and 6 without involving
calmodulin (Iyengar, 1993). AC type 1 or 3 has not been detected
in human T cells; however, several reports support that AC in
human T cells is activated by Ca2+/calmodulin (Kvanta et al, 1990;
Bihoreau et al, 1991). In our study, Dp activated PLC and induced
the proliferative response both in AD T cells and in Dp-speci®c
Th1 cell lines from normal donors; however, Dp activated AC only
in AD T cells showing an IL-13 response to Dp, and did not in the
nonatopic Th1 cell lines showing an IFN-g response to Dp. It is
thus possible that the Dp-induced activation of AC may favor the
IL-13 production over IFN-g, and this possibility should further be
examined. Presumably, the AC of the Dp-responsive T cell
population from AD patients may be more susceptible to the
activation by protein kinase C and/or Ca2+/calmodulin, indicating
the abundance of AC types 2 and 7 and/or 1 and 3. On the other
hand, the AC of Dp-speci®c Th1 cell lines from normal donors
may be less sensitive to such activation and/or may be inhibited by
the Ca2+ signal, indicating the low proportion of AC types 2 and 7
or 1 and 3 and/or the contribution of AC types 5 and 6. Further
studies should elucidate the possible difference in AC isotype by
generating Dp-speci®c T cell clones from AD patients and normal
donors and clarifying the AC isotype of each clone. Another
possible difference is that the culture of T cells and monocytes from
AD patients may contain higher amounts of endogenous AC
agonists, such as prostaglandins, as compared with the culture from
normal donors; such AC agonists also may facilitate the activation
of AC by PLC-mediated signals. It is reported that the
prostaglandin E2 production of monocytes is markedly enhanced
in AD patients compared with normal donors (Chan et al, 1993).
Bihoreau et al (1991) also reported that cAMP increase by anti-
CD3 antibody alone was only slight in magnitude but was
markedly potentiated by the combination with AC agonists such as
prostaglandin E2, cholera toxin, or forskolin. As opposed to Dp,
Th1-antigen PPD did not induce the activation of AC in AD T
cells. Possibly, Dp-responsive T cells from AD patients may be a
distinct population among whole T cells, and may have the AC
isotype, which is much more sensitive to activation by PLC-
mediated signals than that of the PPD-responsive T cell population.
This possibility should further be investigated by establishing Dp-
and PPD-speci®c T cell clones from AD patients.
The activation of PDE by Dp occurred after that of AC in AD T
cells. Among various PDE isotypes, only PDE4 appeared to be
activated by Dp, and was required for Dp-induced IL-13
production. The Dp-induced activation of PDE was inhibited by
protein kinase A inhibitor, H-89 and AC inhibitor MDL 12,330A.
These results indicate the involvement of AC and protein kinase A
in the Dp-induced activation of PDE4. It is also reported that
protein kinase A promotes the activity of PDE4D3 by phosphor-
ylation at serine54 (Sette and Conti, 1996). Possibly, Dp may
initially activate AC and generate cAMP signals, which may
promote protein kinase A activity, and this kinase may thus
phosphorylate and activate PDE4 (Fig 7). Then the activated PDE4
may hydrolyze cAMP and thus reverse the cAMP amount and
protein kinase A activity to basal level. This appears the negative
feedback control by cAMP-related signaling pathways. PDE4
inhibitor, rolipram retained the elevated cAMP level after Dp
stimulus, and this led to the suppression of IL-13 production. It is
thus indicated that the prolonged accumulation of cAMP may
downregulate IL-13 production. Possibly, protein kinase A may
have a dual function; it may promote the early step of IL-13
production whereas in the later phase, it may act negatively. One
possible mechanism for the inhibition is that protein kinase A may
promote the degradation of IL-13 mRNA. It is also reported that
cAMP-elevating agents decrease the stability of IL-4 mRNA in
anti-CD3/anti-CD28-activated human T cells (Borger et al, 1996).
Another possible mechanism is that protein kinase A may suppress
the activity of PLC, which is initially promoted by the antigen
stimulation of TCR (Fig 7). It is reported that protein kinase A
phosphorylates PLC-g1 at serine1248 and thus interferes with the
tyrosine phosphorylation of PLC-g1, and this reduces the activity of
this enzyme (Park et al, 1992). The inhibition by cAMP may also
occur at post-translational level; it is reported that the accumulation
of cAMP inhibits the assembly of microtubules in the Golgi/trans-
Golgi area, and thus interrupts the intracellular transport and
secretion of proteins (Lichtenstein and Henney, 1974; Bennet et al,
1984), and this may be the case for IL-13.
Dp- or PPD-induced IFN-g production was not blocked by the
AC inhibitor and thus may not require the activation of AC and the
resultant cAMP signal. Beside the cAMP-elevating agent, rolipram
inhibited the Dp- or PPD-induced IFN-g production. These
suggest that cAMP may only inhibit IFN-g production without
stimulatory effects. Recent studies suggest that the inhibition may
occur mainly at transcriptional level; the proximal element of the
IFN-g promoter contains binding sites for AP-1 and for CREB/
ATF-1, which are overlapping (Aune et al, 1997). When protein
kinase A is activated by cAMP, it phosphorylates CREB and/or
ATF-1, and thus enhances their binding to the IFN-g promoter.
The binding of CREB and/or ATF-1 to the IFN-g promoter
competitively inhibits the binding of AP-1, and thus represses the
transcriptional activity of the promoter (Penix et al, 1996; Zhang
et al, 1998). Such competitive inhibition by CREB/ATF-1 does
not occur at the AP-1 binding site on the IL-2 or IL-4 promoter
and thus may be speci®c to the IFN-g promoter (Zhang et al, 1998).
The inhibitory effects of cAMP on IFN-g production may also
occur at the pretranscriptional or post-transcriptional level, some of
which may be common to those on IL-13 production as described
above.
In this study, PDE4 and AC inhibitors suppressed Dp-induced
IL-13 production of AD T cells. This indicates that these agents
may also in vivo suppress the Dp-speci®c IgE synthesis via the
Figure 8. Signal transducing enzyme inhibi-
tors' effects on Dp-induced activation of AC
and PDE in T cells from AD patients. (a) AC;
(b) PDE. T cells from AD patients were preincu-
bated for 30 min with medium alone or with
medium containing signal transducing enzyme in-
hibitors, washed, and then added to autologous
Dp-pulsed or nonpulsed monocytes. AC activity
of T cells was analyzed at 5 min and that of PDE
was analyzed at 15 min of the culture, respectively.
The inhibitors were MDL 12,330A (5 mM), ET-
18-OCH3 (1 mM), BAPTA/AM (10 mM), W-7
(50 mM), calphostin C (0.1 mM), rolipram (5 mM),
milrinone (10 mM), 8mmIBMX (10 mM), H-89
(0.1 mM), and Rp-8-Br-cAMPS (10 mM). The
data are mean 6 SEM (n = 7). *p < 0.05 versus
control cultures with Dp-nonpulsed monocytes.
²p < 0.05 versus cultures with Dp-pulsed mono-
cytes without inhibitor preincubation.
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inhibition of IL-13 production and thus prevent the development
of AD. In particular, the AC inhibitor blocked Dp-induced IL-13
production without reducing that of IFN-g. To date, the
therapeutic ef®cacy of the AC inhibitor has not been reported
and thus the drug may provide a new insight into the treatment of
AD patients. We are now studying if the AC or PDE4 inhibitor
may in vitro suppress the Dp-speci®c IgE synthesis in peripheral
blood mononuclear cells from AD patients.
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